🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
✕
Login
Home
News
Messages
Startup Showcase
Trackers
Premium
Premium Content
Jobs
Notifications
Settings
Try our Valuation Calculator →
Log In
News on Medial
Reinventing Serum
Business Today
·
2m ago
Medial
Serum Institute of India is evolving under Adar Poonawalla's leadership, shifting focus from Covid-19 vaccine supremacy to research-driven innovation and diverse investments. As pandemic revenues stabilize, SII is developing India's first indigenous HPV vaccine and pursuing US and EU regulatory approvals. The company also diversifies into diagnostics, financial services, and film production. This corporate reinvention mirrors broader industry changes, alongside insights into Pakistan's economic decline. The June 8 issue explores these themes extensively.
View Source
1
Related News
Bio-tech startup Cellivate Technologies raises $1 Mn in seed round
Entrackr
·
1y ago
Medial
Bio-tech startup Cellivate Technologies has raised $1 million in a seed round led by Antler along with participation from Venture Catalysts, Hatcher+, and We Founder Circle. The funds will be used to accelerate its R&D efforts, scale up production of its innovative products, and expand its market reach, Cellivate said in a press release. Launched by Viknish Krishnan Kutty, Cellivate is developing innovative solutions to address critical challenges in cell culture and biomanufacturing. The company’s flagship products include advanced microcarriers for scaling up cell growth and a novel cell-based serum designed to replace fetal bovine serum. According to market research, the cell culture market, especially concerning microcarriers and serum, is expected to reach $33 billion by 2030. Cellivate says that its advanced microcarriers and cell-based serum alternatives have the potential to reduce costs, increase efficiency, and address ethical concerns in cell culture processes. Advancements in cell culture and biomanufacturing-related technologies will reduce society’s dependence on animal slaughter since several products/ingredients conventionally derived from animals can be procured from cells.
View Source
Which are the most valuable unlisted firms in India as per Hurun?
Inshorts
·
5m ago
Medial
The National Stock Exchange of India (NSE) has topped Axis Bank and Hurun India's list of most valuable unlisted companies in India as of 2024, with a valuation of ₹4.7 lakh crore. It's followed by Serum Institute of India, Zoho Corporation, Zerodha, Megha Engineering & Infrastructures, Parle Products, Intas Pharmaceuticals, Dream11, Razorpay and Amalgamations.
View Source
Indian space startups shouldn't copy ISRO: Ex-ISRO scientist Narayanan
Inshorts
·
1y ago
Medial
Former ISRO scientist Nambi Narayanan said he's not "too happy" with the work done by Indian space startups as they can produce better take-off platforms. "Our space startups are too focused on reinventing the wheel. They shouldn't be duplicating what ISRO is already doing," Narayanan said. He added that the startups must venture into areas where ISRO doesn't have expertise.
View Source
Exclusive: Poonawalla's Serum Institute eyes medtech foray with global acquisition
VCCircle
·
1y ago
Medial
The Serum Institute of India (SII), the largest vaccine manufacturer globally, is considering acquiring a stake in a foreign medical technology company. The company's CEO, Adar Poonawalla, is reportedly in advanced discussions about investing in a US-based firm. SII aims to expand its presence in the healthcare industry beyond vaccine production. However, further details regarding the potential acquisition are yet to be disclosed.
View Source
Wander Raises $50 Million Series B Led by QED, Total Funding $100M+, Expands to 1,000+ Locations | DeepNewz VC
Business Bytes
·
2m ago
Medial
Wander has successfully raised $50 million in a Series B funding round, bringing its total funding to over $100 million. The round was led by QED Investors and Fifth Wall, with participation from Redpoint. This investment aims to support Wander's mission of reinventing luxury travel. As the company expands, founder and CEO John Andrew Entwistle shares insights into Wander's continued growth and vision for the future.
View Source
Google I/O 2025 live blog: Gemini takes center stage
The Verge
·
2m ago
Medial
Google I/O 2025 at the Shoreline Amphitheater focuses heavily on AI developments, particularly the Gemini 2.5 model, amid pressures from competitors like ChatGPT. Google is attempting to solidify its AI leadership, revealing plans for AR glasses and updates on self-driving cars, despite facing potential breakup due to monopoly concerns in search and advertising. Google’s challenges include reinventing itself while maintaining its massive scale and dominance in the tech industry.
View Source
TPG buys 35% stake in Schott Poonawalla, brings Novo Holdings as co-investor
VCCircle
·
3m ago
Medial
TPG has acquired a 35% stake in Schott Poonawalla, a joint venture between Serum Institute of India (SII) and Schott Pharma. Novo Holdings is co-investing alongside TPG. Following the deal, SII retains a minority stake. Schott Poonawalla specializes in drug containment and delivery solutions. The investment supports its growth and expansion. The transaction is set to close in 2025, and TPG cites its healthcare expertise as key to this strategic move.
View Source
Carlyle-backed Hexaware taps i-banks for IPO; Mankind Pharma eyes Bharat Serum
VCCircle
·
1y ago
Medial
US private equity firm Carlyle has selected a group of five investment banks, including Kotak Mahindra Capital, Citi, JP Morgan, IIFL Capital, and HSBC Securities, to assist with the IPO of Hexaware Technologies. This move is aimed at allowing Carlyle to sell a portion of its stake in the portfolio company. In other news, Indian pharmaceutical company Mankind Pharma is reportedly considering acquiring Bharat Serum and Vaccines in a deal that could be worth $690 million.
View Source
Efficacy-driven premium beauty brand WishCare crosses Rs 300 crore in ARR
IndianStartupNews
·
1m ago
Medial
WishCare, an Indian premium beauty brand co-founded by Stuti, Ankit, and Ayush Kothari in 2020, has reported achieving a Rs 300 crore annual run rate (ARR) and Rs 200 crore in FY 2024–25 revenue. Following Unilever Ventures' investment, the brand grew 10x in 18 months and served over 5 million customers. Specializing in high-performance products like Hair Growth Serum and SPF Lip Balm, WishCare plans international expansion into markets like the UAE, USA, and Southeast Asia.
View Source
From the brink of failure to a bold new blueprint: How Fittr was revived from the collapse
YourStory
·
3m ago
Medial
During the pandemic, Pune-based Fittr thrived as an online health and wellness platform. However, after significant funding and ambitious growth efforts, it faced financial challenges. By 2022, as gyms reopened, Fittr's heavy spending led to mounting losses. They pivoted by cutting costs and reinventing services, turning to health diagnostics as a new focus. This led to successful product launches like Fittr HART and a broader vision of becoming an end-to-end healthcare company, driving profitability and growth.
View Source
Trackers
Active Indian VC’s
OG Capital
Email
With a hands-on approach, OG Capital aims to invest in over 20 promising...
Accel Partners
Email
Early and growth-stage investments in disruptive technology companies with...
Blume
Email
Early-stage venture capital firm investing in technology startups in India. Focus on...
Access All Trackers
Startup Showcase Winners
June 2025
Buddy
Helping your parents when you are miles away
BiteStop
The Pit Stop Your Cravings Deserve
Bloomer
The next generation E-commerce platform
Enter Ongoing Startup Showcase
Top Users
Trending News on Medial
Download the medial app to read full posts, comements and news.
Go to Medial App
Not Now
Know everything that’s happening in the startup ecosystem, first.
Enable Notifications?
No, thanks
Count me in
/indianstartupnews/media/agency_attachments/s1FnhAYONODoxNkoC8xA.png)
